Financing round-up: Insilico Medicine, MedGenome, Bactolife, Healee, eTheRNA

Belgium: eTheRNA, an mRNA technologies company, has raised €39m (US$38.8m) in a Series B2 financing to expand investment in its integrated mRNA technology platform and further pursue its new initiatives for a partnership-driven business strategy. The round was led by Novalis LifeSciences with participation from Professor Kenneth Chien, a world-renowned expert in mRNA technology and…

You must be a HMI Subscriber to view this content.

Subscribe Now »